Related Experiment Video

Updated: Aug 9, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Rapid sterilisation of cerebrospinal fluid in meningococcal meningitis: Implications for treatment duration

Julie M Crosswell1, W Ross Nicholson, Diana R Lennon

  • 1South Auckland Clinical School, University of Auckland, New Zealand.

Journal of Paediatrics and Child Health
|April 25, 2006
PubMed

Insights

Children with meningococcal meningitis (MM) achieved sterile cerebrospinal fluid (CSF) within 6 hours of antibiotic treatment. A cumulative antibiotic dose of 150 mg/kg ensured CSF sterilization, supporting shorter treatment durations.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Clinical Pharmacology

Background:

  • Meningococcal meningitis (MM) is a serious bacterial infection requiring prompt antibiotic treatment.
  • Determining optimal antibiotic dosing and duration is crucial for effective patient outcomes and preventing resistance.

Purpose of the Study:

  • To establish the time and cumulative parenteral antibiotic dose needed to achieve cerebrospinal fluid (CSF) sterilization in pediatric MM.
  • To evaluate the relationship between antibiotic exposure and CSF bacterial clearance.

Main Methods:

  • Retrospective audit of pediatric patients (0-14 years) with confirmed MM between 1995-1999.
  • Analysis of CSF cultures and Gram stains from patients undergoing lumbar puncture (LP) at least 1 hour after antibiotic initiation.
  • Correlation of cumulative antibiotic dose and time to LP with CSF sterilization.

Main Results:

  • CSF sterilization was achieved in all patients (n=24) receiving a cumulative antibiotic dose of at least 150 mg/kg prior to LP.
  • No Neisseria meningitidis growth was observed in CSF samples taken more than 5 hours after commencing antibiotics.
  • The mean age of the 48 identified children was 4.4 years.

Conclusions:

  • Pediatric patients with MM demonstrate rapid CSF sterilization (<6 hours) with appropriate antibiotic therapy.
  • Findings support current recommendations for reducing antibiotic duration to 4 days for MM.
  • Further research is needed on long-term sequelae associated with shorter antibiotic treatment durations.
Abstract

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.